Sub: Covid Medicine. - DRDO

Skip to first unread message

Sanjeev Goyal

May 18, 2022, 10:30:59 AMMay 18
to dwarka-residents


DWARKA FORUM Dwarka Ki Awaaz

                                          (Regn No. S-63070)                            

      (A Welfare Association of Residents & RWA's / CGHS Representatives of Dwarka Sub-City)


Regd. Office:

720, Pocket-1, Sector-14,

Dwarka, New Delhi - 110078  

Phone No. 011-20514195



No. SKG/PMO/228                                                     18 May 2022


Sh. Narender Modi,

Prime Minister,

7 Lok Kalyan Marg,


Sir,                                            PMOPG/E/2022/0136634                 

Sub: Covid Medicine.

Concerning Department: DRDO

DRDO had invented a drug i.e. 2-DG Anti-COVID Oral Drug effective against all coronavirus variants. At the time of launch, it was cited to be effective against cancer as well and hit the headlines of all news channels. The emergency use of the drug was also approved to fight against COVID. The same was formally launched on 17 May 2021. However, there is no publicity about this drug now and most of the people are not aware about this. The drug was launched with a high degree of confidence by the DRDO scientists. Its anti-cancer properties have made it a much-wanted medicine to fight the deadly and costly cancer treatment. All know that there is a big pharma lobby working throughout the world to protect its business interest. It is quite possible that this cheap drug may not have been able to sustain the pressure of the lobby and lost in the crowd. At present, there is no discussion of this drug anywhere. So either this has proved ineffective or has failed to protect its existence against powerful & influential pharma lobby.

In view of this, it is requested that DRDO may be advised to come out in public with the latest status about the efficacy, commercial production, and other related facts about this medicine.



S K Goyal

Vice President

D-103, Shivam Apartment,

Sector-12/14, Dwarka,

New Delhi-110078.

Reply all
Reply to author
0 new messages